Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights on February 27, 2025
Novavax (NVAX) has announced it will host a conference call on Thursday, February 27, 2025, at 8:30 a.m. Eastern Time to discuss its fourth quarter and full year 2024 financial results and operational highlights. The company, which specializes in protein-based vaccines with its Matrix-M™ adjuvant technology, will provide participants with options to join the call either through automated registration or operator assistance.
Novavax (NVAX) ha annunciato che terrà una conferenza telefonica giovedì 27 febbraio 2025, alle 8:30 ora orientale per discutere i suoi risultati finanziari del quarto trimestre e dell'intero anno 2024 e i punti salienti operativi. L'azienda, specializzata in vaccini a base proteica con la sua tecnologia di adiuvante Matrix-M™, offrirà ai partecipanti la possibilità di unirsi alla chiamata sia tramite registrazione automatica che assistenza dell'operatore.
Novavax (NVAX) ha anunciado que llevará a cabo una conferencia telefónica el jueves 27 de febrero de 2025, a las 8:30 a.m. hora del este para discutir sus resultados financieros del cuarto trimestre y del año completo 2024 y los aspectos destacados operativos. La compañía, que se especializa en vacunas a base de proteínas con su tecnología de adyuvante Matrix-M™, proporcionará a los participantes opciones para unirse a la llamada a través de registro automatizado o asistencia de un operador.
노바백스(NVAX)는 2025년 2월 27일 목요일 오전 8시 30분 동부 표준시에 회의 전화를 개최하여 2024년 4분기 및 전체 연도 재무 결과와 운영 하이라이트에 대해 논의할 것이라고 발표했습니다. 단백질 기반 백신과 Matrix-M™ 보조제 기술을 전문으로 하는 이 회사는 참가자들이 자동 등록 또는 운영자 지원을 통해 통화에 참여할 수 있는 옵션을 제공할 것입니다.
Novavax (NVAX) a annoncé qu'elle organisera une conférence téléphonique le jeudi 27 février 2025, à 8h30, heure de l'Est pour discuter de ses résultats financiers du quatrième trimestre et de l'année complète 2024 ainsi que des points forts opérationnels. L'entreprise, spécialisée dans les vaccins à base de protéines avec sa technologie d'adjuvant Matrix-M™, offrira aux participants des options pour rejoindre l'appel soit par enregistrement automatisé, soit avec l'assistance d'un opérateur.
Novavax (NVAX) hat angekündigt, dass am Donnerstag, den 27. Februar 2025, um 8:30 Uhr Eastern Time eine Telefonkonferenz stattfinden wird, um über die Finanzergebnisse des vierten Quartals und des gesamten Jahres 2024 sowie über operative Highlights zu diskutieren. Das Unternehmen, das auf proteinbasierte Impfstoffe mit seiner Matrix-M™ Adjuvantechnologie spezialisiert ist, wird den Teilnehmern die Möglichkeit bieten, entweder über eine automatisierte Registrierung oder über die Unterstützung eines Operators an der Konferenz teilzunehmen.
- None.
- None.
Conference call details: | |
Date: | February 27, 2025 |
Time: | 8:30 a.m. |
URL to register phone: | |
Dial-in number: | (800) 836-8184 (Domestic) or |
(+1) (646) 357-8785 (International) | |
Webcast: |
- Participants can join the conference call without operator assistance by registering and entering their phone number with the above URL to receive an instant automated call back.
- Participants can also dial direct to be entered into the call by an operator and will be prompted to request to join the Novavax, Inc. call.
- To ensure a timely connection, it is recommended that participants join at least 10 minutes prior to the scheduled webcast.
Replay details: | |
Date: | Available starting at 11:30 a.m. |
Dial-in number: | (888) 660-6345 (Domestic) or |
(+1) (646) 517-4150 (International) | |
Passcode: | 79349# |
Webcast: | ir.novavax.com/events, until March 29, 2025 |
About Novavax
Novavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to help protect against serious infectious diseases. Novavax, a global company based in
Contacts:
Investors
Luis Sanay, CFA
240-268-2022
ir@novavax.com
Media
Giovanna Chandler
202-709-5563
media@novavax.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-host-conference-call-to-discuss-fourth-quarter-and-full-year-2024-financial-results-and-operational-highlights-on-february-27-2025-302381190.html
SOURCE Novavax, Inc.
FAQ
When will Novavax (NVAX) report Q4 and full year 2024 earnings?
How can investors join the Novavax (NVAX) Q4 2024 earnings call?
What will be discussed in Novavax's (NVAX) February 27 conference call?
What time should participants join the Novavax (NVAX) earnings call?
